- Home
- TAK vs ACGL Comparison
TAK vs ACGL Comparison
Compare TAK & ACGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- ACGL
- Stock Information
- Founded
- TAK 1781
- ACGL 2001
- Country
- TAK Japan
- ACGL Bermuda
- Employees
- TAK N/A
- ACGL N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- ACGL Property-Casualty Insurers
- Sector
- TAK Health Care
- ACGL Finance
- Exchange
- TAK Nasdaq
- ACGL Nasdaq
- Market Cap
- TAK 43.9B
- ACGL 37.9B
- IPO Year
- TAK N/A
- ACGL 1995
- Fundamental
- Price
- TAK $13.63
- ACGL $101.83
- Analyst Decision
- TAK
- ACGL Buy
- Analyst Count
- TAK 0
- ACGL 16
- Target Price
- TAK N/A
- ACGL $119.25
- AVG Volume (30 Days)
- TAK 1.3M
- ACGL 2.1M
- Earning Date
- TAK 10-31-2024
- ACGL 10-30-2024
- Dividend Yield
- TAK 4.65%
- ACGL N/A
- EPS Growth
- TAK 49.73
- ACGL 91.75
- EPS
- TAK 1.27
- ACGL 14.88
- Revenue
- TAK $31,732,209,416.00
- ACGL $16,867,000,000.00
- Revenue This Year
- TAK $4.41
- ACGL N/A
- Revenue Next Year
- TAK $1.09
- ACGL $12.80
- P/E Ratio
- TAK $21.56
- ACGL $6.84
- Revenue Growth
- TAK 9.43
- ACGL 32.50
- 52 Week Low
- TAK $12.58
- ACGL $72.85
- 52 Week High
- TAK $15.08
- ACGL $116.47
- Technical
- Relative Strength Index (RSI)
- TAK 39.22
- ACGL 45.86
- Support Level
- TAK $13.46
- ACGL $99.64
- Resistance Level
- TAK $13.75
- ACGL $102.13
- Average True Range (ATR)
- TAK 0.16
- ACGL 2.19
- MACD
- TAK -0.01
- ACGL 0.34
- Stochastic Oscillator
- TAK 21.15
- ACGL 58.90
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About ACGL Arch Capital Group Ltd.
Arch Capital Group Ltd is a Bermuda company which writes insurance and reinsurance with operations in Bermuda, the United States, Canada, Europe, Australia and United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage two operating segments: corporate and other. The insurance segment provides specialty risk solutions to client across a variety of industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.